Kesimpta vs. Ocrevus: Key Differences in MS Treatment

Explore the differences between Kesimpta and Ocrevus for treating multiple sclerosis (MS). Learn about their uses, dosages, side effects, and effectiveness to choose the best option for your condition.

  Prescription Medicines   Jan 7, 2025   0  Add to Reading List
Kesimpta vs. Ocrevus: Key Differences in MS Treatment

Kesimpta vs. Ocrevus: Which MS Treatment is Right for You?

When managing multiple sclerosis (MS), choosing the right treatment can make a significant difference in your health and quality of life. Kesimpta (ofatumumab) and Ocrevus (ocrelizumab) are two prescription medications used to treat MS. Both are highly effective but differ in administration, dosage, and other factors.

This article provides a detailed comparison of Kesimpta and Ocrevus to help you and your doctor make an informed decision.

Understanding the Basics

What Are Kesimpta and Ocrevus?

  • Kesimpta: A biologic medication that targets B cells, reducing the activity of the immune system that can damage nerves.
  • Ocrevus: A similar biologic drug that also targets B cells, used to treat primary progressive MS (PPMS) in addition to other forms of MS.

Both drugs are not available as biosimilars and come as liquid solutions for injection.

Uses for Each Drug

Condition Kesimpta Ocrevus
Clinically Isolated Syndrome (CIS) ✅ ✅
Relapsing-Remitting MS (RRMS) ✅ ✅
Active Secondary Progressive MS (SPMS) ✅ ✅
Primary Progressive MS (PPMS) ❌ ✅

Administration and Dosage

Kesimpta

  • Form: Subcutaneous injection using a prefilled syringe or injection pen.
  • Dosage:
    • Initial doses at 0, 1, 2, and 4 weeks.
    • Maintenance doses every 4 weeks.
  • Administration: Self-administered under the skin in the abdomen, thigh, or upper arm.

Ocrevus

  • Form: Intravenous (IV) infusion.
  • Dosage:
    • Initial doses at 0 and 2 weeks.
    • Maintenance doses every 6 months.
  • Administration: Administered by healthcare professionals in a clinic or infusion center.

Side Effects of Kesimpta and Ocrevus

Mild Side Effects

Side Effect Kesimpta Ocrevus
Back pain ✅ ✅
Injection site reactions ✅ ❌
Whole-body reactions ✅ ❌
Depression ❌ ✅
Cough ❌ ✅

Serious Side Effects

Both drugs may cause:

  • Increased risk of infections, including progressive multifocal leukoencephalopathy (PML).
  • Reduced levels of immunoglobulins.

Ocrevus additionally carries a risk of colitis, infusion reactions, and increased cancer risks (e.g., breast cancer).

Pro Tip: Always report side effects to your doctor, especially if they worsen or persist.

Effectiveness Comparison

Both Kesimpta and Ocrevus have shown excellent efficacy in managing MS symptoms and reducing relapses. However, individual responses can vary.

Kesimpta Highlights:

  • Convenient self-administration at home.
  • Monthly dosing ensures steady treatment.

Ocrevus Highlights:

  • Effective for a broader range of MS types, including PPMS.
  • Semi-annual dosing may appeal to those seeking fewer treatments.

Cost Considerations

Both Kesimpta and Ocrevus are brand-name drugs, and neither is available as a generic or biosimilar. Costs can vary depending on insurance coverage, dosage, and pharmacy.

Cost-Saving Tips:

  • Check for manufacturer savings programs.
  • Explore patient assistance options.

Switching Between Kesimpta and Ocrevus

Switching between these medications is possible under a doctor’s guidance. Reasons for switching may include side effects, effectiveness, or lifestyle preferences.

Frequently Asked Questions

1. Can I use Kesimpta and Ocrevus together?
No, using these drugs together is not recommended due to the increased risk of infections.

2. Which is better for PPMS, Kesimpta or Ocrevus?
Ocrevus is specifically approved for PPMS, while Kesimpta is not.

3. Are there oral alternatives to Kesimpta and Ocrevus?
Yes, oral drugs like Mavenclad (cladribine) are available but differ in usage and effects. Discuss with your doctor for suitability.

4. Do these drugs affect pregnancy?
Both drugs may pose risks during pregnancy. Discuss family planning with your doctor before starting treatment.

5. Are there dietary restrictions while using Kesimpta or Ocrevus?
No specific dietary restrictions apply, but maintaining a healthy diet can support overall wellness during treatment.

Conclusion

Kesimpta and Ocrevus are highly effective options for managing multiple sclerosis. Your choice should be guided by your specific MS type, lifestyle needs, and doctor’s recommendations. Always prioritize regular consultations and adherence to prescribed treatment for the best outcomes.

Tags